LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $261,000 | +28.6% | 1,688 | +15.8% | 0.01% | +20.0% |
Q3 2021 | $203,000 | -7.7% | 1,458 | +0.8% | 0.01% | 0.0% |
Q1 2021 | $220,000 | -28.1% | 1,446 | -54.9% | 0.01% | -44.4% |
Q3 2020 | $306,000 | -17.5% | 3,206 | -3.3% | 0.01% | -18.2% |
Q2 2020 | $371,000 | +57.2% | 3,316 | +2.2% | 0.01% | +37.5% |
Q1 2020 | $236,000 | -31.4% | 3,246 | -1.5% | 0.01% | -11.1% |
Q4 2019 | $344,000 | +42.7% | 3,296 | +35.9% | 0.01% | +28.6% |
Q3 2019 | $241,000 | -18.0% | 2,426 | -5.8% | 0.01% | -12.5% |
Q2 2019 | $294,000 | -18.1% | 2,576 | -9.9% | 0.01% | -20.0% |
Q1 2019 | $359,000 | -6.8% | 2,859 | +0.7% | 0.01% | -16.7% |
Q4 2018 | $385,000 | -55.6% | 2,839 | -10.1% | 0.01% | -45.5% |
Q3 2018 | $867,000 | +24.2% | 3,159 | -6.2% | 0.02% | +15.8% |
Q2 2018 | $698,000 | +31.7% | 3,368 | +5.1% | 0.02% | +35.7% |
Q1 2018 | $530,000 | +15.0% | 3,206 | -4.8% | 0.01% | +27.3% |
Q4 2017 | $461,000 | +8.5% | 3,366 | +7.8% | 0.01% | 0.0% |
Q3 2017 | $425,000 | 0.0% | 3,123 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $425,000 | – | 3,123 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
RK Capital | 174,283 | $8,190,000 | 1.67% |
Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |